Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locoregional Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Not applicableActive Not RecruitingNCT03583580
What this trial is testing

Accelerated Partial Breast Irradiation With IMRT in Early Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasm Recurrence, Local
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 537
Large-scale testing (Phase 3)Not Yet RecruitingNCT07686796
What this trial is testing

Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial

Who this might be right for
Local Advanced Rectal CancerPD-1 InhibitorPCSK9 Inhibitor+4 more
Guangdong Provincial People's Hospital 148
Not applicableStudy completedNCT04337060
What this trial is testing

Open Radical Prostatectomy and Erector Spinae Plane Block

Who this might be right for
Prostate CancerAnesthesia, LocalPain, Postoperative
BURHAN DOST 52
Testing effectiveness (Phase 2)Study completedNCT00961896
What this trial is testing

A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients

Who this might be right for
Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients
Novartis Pharmaceuticals 18
Large-scale testing (Phase 3)UnknownNCT00887380
What this trial is testing

STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing)

Who this might be right for
Breast Cancer
Trans Tasman Radiation Oncology Group 2,023
Not applicableStudy completedNCT03514433
What this trial is testing

Translating Research Into Practice: Patient Navigation for Breast Cancer

Who this might be right for
Cancer, Breast
Boston Medical Center 1,725
Testing effectiveness (Phase 2)Study completedNCT00005049
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer

Who this might be right for
Colorectal CancerGastric CancerGastrointestinal Carcinoid Tumor+4 more
NYU Langone Health 45
Not applicableUnknownNCT04713917
What this trial is testing

Evaluation of Innovative Therapeutic Approaches of Vaginal and Sexual Dysfunction After Breast Cancer Treatment

Who this might be right for
Breast Cancer
Assistance Publique - Hôpitaux de Paris 330
Large-scale testing (Phase 3)Ended earlyNCT02974426
What this trial is testing

To Evaluate the Optimal Timing of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage IIIARadiotherapy
Shanghai Chest Hospital 132
Testing effectiveness (Phase 2)Study completedNCT03944915
What this trial is testing

De-Escalation Therapy for Human Papillomavirus Negative Disease

Who this might be right for
Human Papilloma VirusSquamous Cell CarcinomaSquamous Cell Carcinoma of the Head and Neck+2 more
University of Chicago 35
Testing effectiveness (Phase 2)UnknownNCT04449289
What this trial is testing

Influence of Local Anesthetic Administration on the Cancer Recurrence Rate After Pancreatic Oncologic Surgery

Who this might be right for
Pancreatic Cancer
Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor 100
Large-scale testing (Phase 3)Active Not RecruitingNCT05417789
What this trial is testing

Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)

Who this might be right for
TGCT
SynOx Therapeutics Limited 128
Testing effectiveness (Phase 2)Study completedNCT00080795
What this trial is testing

Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
M.D. Anderson Cancer Center 65
Not applicableStudy completedNCT06299930
What this trial is testing

Locoregional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy

Who this might be right for
Breast Cancer
Seoul National University Hospital 10,328
Testing effectiveness (Phase 2)UnknownNCT00081536
What this trial is testing

Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies

Who this might be right for
Colorectal Neoplasms
Aronex Pharmaceuticals 105
Not applicableLooking for participantsNCT07469267
What this trial is testing

Level I-II Axillary Irradiation in Breast Cancer With Sentinel-Node Macro-metastases

Who this might be right for
Breast CancerRadiotherapy
Fudan University 1,608
Not applicableUnknownNCT03356236
What this trial is testing

Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation

Who this might be right for
Hepatocarcinoma
Yue Han 828
Testing effectiveness (Phase 2)Ended earlyNCT04106492
What this trial is testing

Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors

Who this might be right for
Cancer
Shasqi, Inc. 53
Not applicableTemporarily pausedNCT03253575
What this trial is testing

CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2

Who this might be right for
Adult Solid Tumor
Mitra RxDx, Inc. 800
Next Page